Source:http://linkedlifedata.com/resource/pubmed/id/21690170
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-7-15
|
pubmed:abstractText |
This study aimed to investigate the role of preproghrelin-derived peptides in adipogenesis. Immunocytochemical analysis of 3T3-L1 adipocyte cells showed stronger preproghrelin expression compared with that observed in 3T3-L1 preadipocyte cells. Insulin promoted this expression throughout adipogenesis identifying mTORC1 as a critical downstream substrate for this profile. The role of preproghrelin-derived peptides on the differentiation process was supported by preproghrelin knockdown experiments, which revealed its contribution to adipogenesis. Neutralization of endogenous O-acyl ghrelin (acylated ghrelin), unacylated ghrelin, and obestatin by specific antibodies supported their adipogenic potential. Furthermore, a parallel increase in the expression of ghrelin-associated enzymatic machinery, prohormone convertase 1/3 (PC1/3) and membrane-bound O-acyltransferase 4 (MBOAT4), was dependent on the expression of preproghrelin in the course of insulin-induced adipogenesis. The coexpression of preproghrelin system and their receptors, GHSR1a and GPR39, during adipogenesis supports an autocrine/paracrine role for these peptides. Preproghrelin, PC1/3, and MBOAT4 exhibited dissimilar expression depending on the white fat depot, revealing their regulation in a positive energy balance situation in mice. The results underscore a key role for preproghrelin-derived peptides on adipogenesis through an autocrine/paracrine mechanism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1479-6805
|
pubmed:author |
pubmed-author:Al-MassadiOmarO,
pubmed-author:Amil-DizMaríaM,
pubmed-author:BeiroaDanielD,
pubmed-author:CamiñaJesús PJP,
pubmed-author:CasanuevaFelipe FFF,
pubmed-author:CrujeirasAna BelénAB,
pubmed-author:GallegoRosalíaR,
pubmed-author:Gurriarán-RodríguezUxíaU,
pubmed-author:MosteiroCarlos SCS,
pubmed-author:NogueirasRubénR,
pubmed-author:PazosYolandaY,
pubmed-author:SeoaneLuisa MaríaLM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
210
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
R1-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:21690170-3T3-L1 Cells,
pubmed-meshheading:21690170-Adipocytes,
pubmed-meshheading:21690170-Adipogenesis,
pubmed-meshheading:21690170-Animals,
pubmed-meshheading:21690170-Insulin,
pubmed-meshheading:21690170-Male,
pubmed-meshheading:21690170-Mice,
pubmed-meshheading:21690170-Peptide Hormones,
pubmed-meshheading:21690170-Protein Precursors,
pubmed-meshheading:21690170-RNA, Small Interfering
|
pubmed:year |
2011
|
pubmed:articleTitle |
Preproghrelin expression is a key target for insulin action on adipogenesis.
|
pubmed:affiliation |
Área de Endocrinología Molecular y Celular, Instituto de Investigación Sanitaria de Santiago (IDIS), Hospital Clínico Universitario de Santiago, Servicio Gallego de Salud (SERGAS), Santiago de Compostela, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|